Danni Harris

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Publications

Filter by Year

Filter by Publication Type

Search Results

Design, synthesis, and structure–activity relationship studies of novel GPR88 agonists (4-substituted-phenyl)acetamides based on the reversed amide scaffold

The development of diphenyleneiodonium analogs as GPR3 agonists

Isoquinolone derivatives as lysophosphatidic acid receptor 5 (LPA5) antagonists: Investigation of structure-activity relationships, ADME properties and analgesic effects

Structure-activity relationship development efforts towards peripherally selective analogs of the cannabinoid receptor partial agonist BAY 59-3074

Rational design of cannabinoid type-1 receptor allosteric modulators: Org27569 and PSNCBAM-1 hybrids

Discovery of arylsulfonamides as dual orexin receptor agonists

Therapeutic and prophylactic vaccines to counteract fentanyl use disorders and toxicity

Blocking alcoholic steatosis in mice with a peripherally restricted purine antagonist of the type 1 cannabinoid receptor

Re-sensitizing multidrug resistant bacteria to antibiotics by targeting bacterial response regulators: Characterization and comparison of interactions between 2-aminoimidazoles and the response regulators bfmr fromand qseb fromspp

Development of a peripherally restricted cb1 receptor antagonist for alcoholic steatosis

Discovery of novel proline-based neuropeptide FF receptor antagonists

GPCR activation: Principle component analysis as a diagnostic signature correlated with SAR

Topoisomerase I (Top1): a major target of FL118 for its antitumor efficacy or mainly involved in its side effects of hematopoietic toxicity?

Effect of substitution on the aniline moiety of the GPR88 agonist 2-PCCA: Synthesis, structure-activity relationships, and molecular modeling studies

Regulation of the apelinergic system and its potential in cardiovascular disease: Peptides and small molecules as tools for discovery

The importance of the 6- and 7-positions of tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor

Effect of 1-substitution on tetrahydroisoquinolines as selective antagonists for the orexin-1 receptor

Identification of N-{[6-chloro-4-(2,6-dimethoxyphenyl)quinazolin-2-yl]carbonyl}-l-leucine (NTRC-808), a novel nonpeptide chemotype selective for the neurotensin receptor type 2

Identifying structural determinants of potency for analogs of apelin-13: Integration of C-terminal truncation with structure-activity

Substituted Tetrahydroisoquinolines as Selective Antagonists for the Orexin 1 Receptor